Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism THR modulators(Thyroid hormone receptor modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Allan-Herndon-Dudley Syndrome | Phase 3 | US | 12 Mar 2022 |